Director Saeli Thomas Louis buys 5,000 shares of ULBI at $5.44; holdings rise to 85,000 shares amid cluster buy pattern
Saeli Thomas Louis, a Director, purchased 5,000 shares of Ultralife Corp at $5.44 per share on 2025-05-14, increasing holdings from 80,000 to 85,000 shares (+6.2%). The stock currently trades at $5.52, only 1.5% above the purchase price, placing it 56.4% below its 52-week high of $12.66 after a 25.8% decline over the past 90 days. Of particular note, this transaction occurs as part of a broader cluster pattern: 3 other insiders also bought ULBI shares within the past 14 days, suggesting coordinated confidence at current levels. The insider's prior purchase of ULBI stock in 2023 demonstrated strong post-purchase performance (90d return +106.7%), demonstrating a track record of well-timed entries at this ticker. The company's fundamentals show stable operations (Revenue $50.7M, Net income $1.9M, Annual revenue growth +3.7%, P/E 17.25) despite the recent stock decline, which may explain the multi-insider buying cluster.